This column, forecasting a Trump election win, last week expressed surprise so many news consumers remain loyal to media ...

The 868-page report of the official inquiry into Australia’s Covid-19 response, like the inquiry itself, is not fit for ...

Controversy followed close on the heels of a recent study on the long-term safety of Covaxin, the Covid-19 vaccine developed by Bharat Biotech in collaboration ...

Where we succeeded, it was the result of good institutions and good decision-making. But that’s not to say we didn’t stumble.

Where that issue does get highlighted is in medical authorities’ responses to the AstraZeneca vaccine risks (particularly ...

Chiropractors for RFK —Three appeals in a pod —The FDA shortage saga —The ghost of elections past And more! Join the conversation here.

A long negative candle was formed on the daily chart after the upside bounce of the last two sessions. The crucial overhead ...

Bond yields are falling, as City investors anticipate tax rises in Rachel Reeves’s first budget.   10:13 ...

While the inquiry gets most things right, as vaccine experts, we argue the government response should be broadened in three ...

Influenza and 2023 to 2024 COVID-19 vaccination coverage is 80.7 and 15.3%, respectively, among health care personnel at ...

Researchers found that influenza vaccination coverage was 80.7% and 45.4% among health care personnel at acute care hospitals and nursing homes.

Coverage lower among health care personnel at nursing homes, while coverage for COVID-19 2023 to 24 vaccine was much lower. HealthDay News — Influenza and 2023 to 2024 COVID-19 vaccination ...